BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23886239)

  • 1. Successful oral desensitization to levothyroxine.
    Fevzi D; Mustafa G; Ozgur K; Cetin T; Abdullah B; Sait Y; Ugur M; Osman S
    Ann Allergy Asthma Immunol; 2013 Aug; 111(2):146-7. PubMed ID: 23886239
    [No Abstract]   [Full Text] [Related]  

  • 2. [Successful oral desensitization to levothyroxine. Report of one case].
    Guzmán MA; Sepúlveda C; Liberman C; Cornejo R; Roizen G; Cereceda D; Lara MF; Álvarez-Cuesta E
    Rev Med Chil; 2018 Mar; 146(3):394-398. PubMed ID: 29999112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity to levothyroxine: A case report of a successful oral desensitization.
    Bahloul N; Ben Mahmoud L; Ghozzi H; Hadjkacem F; Zeghal K; Abid M; Kammoun S
    Therapie; 2018 Sep; 73(4):349-350. PubMed ID: 29373130
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful rapid desensitization to methylprednisolone sodium hemisuccinate: a case report.
    Angel-Pereira D; Berges-Gimeno MP; Madrigal-Burgaleta R; Ureña-Tavera MA; Zamora-Verduga M; Alvarez-Cuesta E
    J Allergy Clin Immunol Pract; 2014; 2(3):346-8. PubMed ID: 24811029
    [No Abstract]   [Full Text] [Related]  

  • 5. Immediate-type hypersensitivity reaction to levothyroxine and desensitization.
    Sala A; Labrador-Horrillo M; Guilarte M; Luengo O; Rueda M; Cardona V
    Ann Allergy Asthma Immunol; 2008 May; 100(5):513-4. PubMed ID: 18517088
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid intravenous cephalosporin desensitization.
    Win PH; Brown H; Zankar A; Ballas ZK; Hussain I
    J Allergy Clin Immunol; 2005 Jul; 116(1):225-8. PubMed ID: 15990801
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug Hypersensitivity: Broadening Horizons.
    Tilles SA
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):xv-xvi. PubMed ID: 28965643
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid desensitization to fluconazole (Diflucan).
    Randolph C; Kaplan C; Fraser B
    Ann Allergy Asthma Immunol; 2008 Jun; 100(6):616-7. PubMed ID: 18592829
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Machado-Joseph disease with trimethoprim-sulphamethoxazole following successful desensitisation.
    Ablin J; Elgan N
    N Z Med J; 2004 Apr; 117(1191):U819. PubMed ID: 15107888
    [No Abstract]   [Full Text] [Related]  

  • 10. Maculopapular eruption to rivastigmine's transdermal patch application and successful oral desensitization.
    Makris M; Koulouris S; Koti I; Aggelides X; Kalogeromitros D
    Allergy; 2010 Jul; 65(7):925-6. PubMed ID: 19889118
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses.
    Lee CW; Matulonis UA; Castells MC
    Gynecol Oncol; 2005 Nov; 99(2):393-9. PubMed ID: 16054201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful rapid intravenous desensitization for radioiodine contrast allergy in a patient requiring urgent coronary angiography.
    Gandhi S; Litt D; Chandy M; Nguyen BM; Jindal NL; Tarlo SM; Overgaard CB
    J Allergy Clin Immunol Pract; 2014; 2(1):101-2. PubMed ID: 24565778
    [No Abstract]   [Full Text] [Related]  

  • 13. Desensitization to lenograstim after a life- threatening reaction to filgrastim.
    Nuñez-Acevedo B; Rodríguez-Jiménez B; Domínguez-Ortega J; González-Montellano E; Ibáñez-Heras N; Enrech-Francés S
    J Investig Allergol Clin Immunol; 2015; 25(2):158-60. PubMed ID: 25997320
    [No Abstract]   [Full Text] [Related]  

  • 14. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions.
    Lee CW; Matulonis UA; Castells MC
    Gynecol Oncol; 2004 Nov; 95(2):370-6. PubMed ID: 15491759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.
    Robinson JB; Singh D; Bodurka-Bevers DC; Wharton JT; Gershenson DM; Wolf JK
    Gynecol Oncol; 2001 Sep; 82(3):550-8. PubMed ID: 11520154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A shortened docetaxel desensitization protocol for use in special cases.
    Zirbs M; Seifert F; Zink A; Ring J; Brockow K
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):391-3. PubMed ID: 22339786
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful desensitization of a fixed drug eruption caused by allopurinol.
    Umpiérrez A; Cuesta-Herranz J; De Las Heras M; Lluch-Bernal M; Figueredo E; Sastre J
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):286-7. PubMed ID: 9500766
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug Hypersensitivity and Desensitizations.
    Castells MC
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):xvii-xviii. PubMed ID: 28965644
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful desensitization to brentuximab vedotin after hypersensitivity reaction.
    Story SK; Petrov AA; Geskin LJ
    J Drugs Dermatol; 2014 Jun; 13(6):749-51. PubMed ID: 24918568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin B12 allergy and successful desensitisation with cyanocobalamin: a case report.
    Kartal O; Gulec M; Demirel F; Yesillik S; Caliskaner Z; Sener O
    Allergol Immunopathol (Madr); 2012; 40(5):324-5. PubMed ID: 22266142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.